CLDI
Price
$0.25
Change
+$0.02 (+8.70%)
Updated
Jul 3 closing price
Capitalization
7.81M
GNNSF
Price
$2.20
Change
-$0.00 (-0.00%)
Updated
Jun 12 closing price
Capitalization
4.2B
Interact to see
Advertisement

CLDI vs GNNSF

Header iconCLDI vs GNNSF Comparison
Open Charts CLDI vs GNNSFBanner chart's image
Calidi Biotherapeutics
Price$0.25
Change+$0.02 (+8.70%)
Volume$551.06K
Capitalization7.81M
Genscript Biotech
Price$2.20
Change-$0.00 (-0.00%)
Volume$500
Capitalization4.2B
CLDI vs GNNSF Comparison Chart in %
Loading...
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNNSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDI vs. GNNSF commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDI is a Buy and GNNSF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (CLDI: $0.25 vs. GNNSF: $2.20)
Brand notoriety: CLDI and GNNSF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDI: 60% vs. GNNSF: 61%
Market capitalization -- CLDI: $7.81M vs. GNNSF: $4.2B
CLDI [@Biotechnology] is valued at $7.81M. GNNSF’s [@Biotechnology] market capitalization is $4.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDI’s FA Score shows that 1 FA rating(s) are green whileGNNSF’s FA Score has 0 green FA rating(s).

  • CLDI’s FA Score: 1 green, 4 red.
  • GNNSF’s FA Score: 0 green, 5 red.
According to our system of comparison, GNNSF is a better buy in the long-term than CLDI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDI’s TA Score shows that 3 TA indicator(s) are bullish while GNNSF’s TA Score has 4 bullish TA indicator(s).

  • CLDI’s TA Score: 3 bullish, 3 bearish.
  • GNNSF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, GNNSF is a better buy in the short-term than CLDI.

Price Growth

CLDI (@Biotechnology) experienced а +7.34% price change this week, while GNNSF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

CLDI is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNNSF($4.2B) has a higher market cap than CLDI($7.82M). GNNSF YTD gains are higher at: 73.228 vs. CLDI (-78.626). CLDI has higher annual earnings (EBITDA): -17.73M vs. GNNSF (-203.82M). GNNSF has more cash in the bank: 1.87B vs. CLDI (10.6M). CLDI has less debt than GNNSF: CLDI (4.71M) vs GNNSF (448M). GNNSF has higher revenues than CLDI: GNNSF (1.01B) vs CLDI (0).
CLDIGNNSFCLDI / GNNSF
Capitalization7.82M4.2B0%
EBITDA-17.73M-203.82M9%
Gain YTD-78.62673.228-107%
P/E RatioN/AN/A-
Revenue01.01B-
Total Cash10.6M1.87B1%
Total Debt4.71M448M1%
FUNDAMENTALS RATINGS
GNNSF: Fundamental Ratings
GNNSF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
50
SEASONALITY SCORE
1..100
38

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDIGNNSF
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
65%
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
61%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
42%
Bearish Trend 3 days ago
55%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
38%
Bullish Trend 3 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
60%
Advances
ODDS (%)
Bullish Trend 3 days ago
50%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
70%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNNSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDGT1.120.03
+2.76%
Ridgetech Inc
FRPH27.240.28
+1.04%
FRP Holdings
SNA321.631.53
+0.48%
Snap-on
FISK8.14N/A
N/A
Empire State Realty OP LP
GNPX0.26-0.01
-3.59%
Genprex

CLDI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDI has been loosely correlated with DYN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDI jumps, then DYN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDI
1D Price
Change %
CLDI100%
+5.09%
DYN - CLDI
38%
Loosely correlated
-2.01%
ORYZF - CLDI
37%
Loosely correlated
N/A
IGMS - CLDI
33%
Loosely correlated
+3.03%
LENZ - CLDI
31%
Poorly correlated
+5.07%
NVCT - CLDI
29%
Poorly correlated
N/A
More

GNNSF and

Correlation & Price change

A.I.dvisor tells us that GNNSF and ORYZF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNNSF and ORYZF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNNSF
1D Price
Change %
GNNSF100%
N/A
ORYZF - GNNSF
24%
Poorly correlated
N/A
ARGNF - GNNSF
23%
Poorly correlated
N/A
CLDI - GNNSF
23%
Poorly correlated
+5.09%
PRLD - GNNSF
20%
Poorly correlated
-0.76%
HNSBF - GNNSF
17%
Poorly correlated
N/A
More